43
Total investments
2
Early stage
2
Mid stage
5
Late stage
30y
Years active
Portfolio
23 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
May 2023
SEALSQ develops the next generation quantum-resistant Semiconductors, PKI and Related Trust Services.
Investor
Feb 2022
Teladoc Health is the global leader in virtual care, delivering and orchestrating care across patients, care providers, platforms and partners – transforming virtual care into a catalyst for how better health happens. Our comprehensive care offerings span primary care, mental health, chronic condition management and more, all integrated on a single platform.
We partner with employers, health plans, hospitals, health systems and other providers to fuel clinical excellence and apply the power of technology to help people live their healthiest lives.
Follow us for industry insights, virtual care trends, client success stories and expert perspectives shaping the future of healthcare.
For more information, please visit www.teladochealth.com or follow @TeladocHealth on X.
Investor
Jan 2022
LifeStance Health is a behavioral health care company focused on providing evidenced-based, medically driven treatment services for children, adolescents and adults suffering from a variety of mental health issues in care settings that include acute inpatient, partial hospitalization, intensive outpatient, outpatient, community-based and in-home.
Our Vision: A truly healthy society where mental and physical healthcare are unified to make lives better.
Our Mission: To help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental healthcare.
Our Values:
* Delivering Compassion - We care for people unconditionally and act with empathy always.
* Building Relationships - We are collaborative, building enduring relationships to achieve more together.
* Celebrating Difference - We respect the diversity of every individual’s lived experiences.
Investor
Jan 2022
As the largest provider of private educational services in China, New Oriental offers education for a lifetime, teaching skills that give students a crucial competitive advantage in the workplace and help improve their quality of life. Our wide range of educational programs, services and products includes English and other foreign language training, overseas and domestic test preparation courses, all-subjects after school tutoring, primary and secondary school education, educational content and software as well as online education.
New Oriental has become the most recognized brand in Chinese private education. Based on founder Michael Yu's groundbreaking vision, our innovative and inspirational instruction combines humorous, interactive teaching techniques with traditional Chinese educational values.
Since our founding in 1993, New Oriental has had over 23.4 million student enrollments, including approximately 2.9 million enrollments in fiscal year 2015. As of November 30, 2015, we had a network of 63 schools, 720* learning centers, 25 New Oriental bookstores and over 5,000 third-party bookstores and over 17,000 teachers in 53 cities, as well as an online network with approximately 11.9 million registered users.
新东方教育科技集团由1993年11月16日成立的北京新东方学校发展壮大而来,作为中国教育培训领域的领头羊,其培训课程、培训人次和学习中心保有量三项均居全国第一。
新东方的业务体系以英语及其他外语培训为核心,涵盖中国、美国和英联邦国家的主要入学考试、能力考试,以及国内中小学教育全科培训课程、服务与产品。新东方在基础教育、职业教育、教育研发、出国咨询、文化产业等方面亦取得骄人业绩。
新东方教育科技集团于2006年9月7日在美国纽约证券交易所成功上市,成为中国大陆首家在美国上市的教育培训机构。
截至2015年5月31日,新东方已经在全国50余座城市设立了60余所学校、31家书店以及800多个学习中心。自成立以来,新东方累计面授学员超过2000万人次。
O
Investor
Jan 2022
Openfit is the place to go to get results and have fun doing it – an all-new digital streaming platform that integrates fitness, nutrition, and wellness together in one place.
We offer world-class fitness programs with workouts designed to reach any goal, perfectly paired nutrition plans, safe and effective supplements, and customized wellness advice. In the process, we’ve searched far and wide to bring together the world’s foremost fitness and nutrition experts to make sure you succeed in reaching your goals.
Whether you’re training for an extreme event, looking to lose weight, or just wanting to live each day a little healthier than the last – you’ll not only find solutions at Openfit, you’ll find inspiration. The kind that powers you through your workout and leaves you feeling pumped to do it again tomorrow. So you can reach your goals…and want to come back for more.
That’s the simplicity of living a healthy, vibrant life – in your own way – every day. We hope you’ll come live yours at Openfit.
Investor
Jan 2022
Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder and other mental health conditions. Based in Malvern, PA, we are a public medical device company (STIM) with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world.
NeuroStar is the #1 TMS choice of doctors, with over 6.4 million treatments performed to date. It is an advanced treatment for depression and other mental health conditions. It is not medication, shock therapy, or surgery. NeuroStar is an outpatient treatment done in as little as 20 minutes for 36 sessions. It promotes neuroplasticity to target mental health where it starts — the brain.
Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world.
If you have questions or comments about NeuroStar, please e-mail us at customersupport@neurostar.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.
Please visit NeuroStar.com/Safety for full safety and prescribing information.
T
Investor
Feb 2021
TYME is an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™) that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system. The Company is currently focused on developing its novel compound, SM-88. The Company believes that early clinical results demonstrated by SM-88 in multiple advanced cancers, including pancreatic, prostate, sarcomas, and breast, reinforce the potential of our emerging CMBT™ pipeline.
For more information about the Company, visit www.tymeinc.com.
Investor
Jan 2020
INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases.
Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools.
For more information, visit www.inovio.com.
Investor
Jan 2020
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.”
Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease.
Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients.
We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured.
To learn more, visit www.modernatx.com.
This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762).
Investor
Apr 2019
Phunware, Inc. (NASDAQ: PHUN) is an enterprise software company specializing in mobile app solutions. We provide businesses with the tools to create, implement and manage custom mobile applications and analytics, digital advertising and location-based services. Phunware is transforming mobile engagement by delivering scalable and personalized mobile app experiences.
Phunware’s mission is to achieve unparalleled connectivity and monetization through widespread adoption of Phunware mobile technologies, by leveraging brands, consumers, partners and digital asset holders and market participants. Phunware is poised to expand its software products and services audience and industry verticals through its new platform, utilize and monetize its patents and other intellectual property rights and interests, and update and reintroduce its digital asset ecosystem for existing holders and new market participants.
Investor
Apr 2019
Overstock.com is an online retailer based in Salt Lake City, Utah that helps customers find the perfect something for their home at the perfect price. With incredible deals on the latest styles and trends, we're making dream homes come true! Over the past 24 years, Overstock has grown from a fledgling startup into the best place to buy home goods online thanks to our creative and hard-working team.
Overstock.com, Inc. owns the Bed Bath & Beyond brand and other intellectual property related to the brand.
Investor
Nov 2018
At Puma Biotechnology, our focus is on bringing innovative therapies to patients to enhance cancer care.
We are thankful to be part of the HER2+ breast cancer community and are passionate about evaluating options that may benefit patients across the breast cancer therapy spectrum.
Investor
2017
GenMark Diagnostics is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. GenMark’s ePlex®: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections.
At GenMark, we’re changing the diagnostics landscape, combining out-of-the-box thinkers and game-changing technology to revolutionize patient care.
Our work atmosphere is dynamic, fast-paced, and patient-focused. We encourage teamwork, while reinforcing the importance of individuality, and encouraging an entrepreneurial spirit. GenMark is not just a job – it’s a way of life. We also provide opportunities to volunteer in the community, participate in sports leagues, and enjoy company social events.
Culture is the cornerstone of what makes GenMark a special place to work. We are proud to embrace a culture of accountability in the work we do.
Investor
2017
Xenetic Biosciences, Inc. (NASDAQ: XBIO) is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.
Additionally, Xenetic is leveraging PolyXen™, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen™ has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation biologic drugs. The Company has an exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. in the field of coagulation disorders and expects to earn royalty payments under this agreement.
Show all 23 investments ↓
Experience · 49 entries
All (49)
Investments (43)
Founder (3)
2023
Investor
May 2023
SEALSQ develops the next generation quantum-resistant Semiconductors, PKI and Related Trust Services.
2022
Investor
Feb 2022
LivePerson (NASDAQ: LPSN) is the leader in predictable conversational AI and digital transformation. The worlds leading brands use our award-winning Conversational Cloud platform to connect with millions of consumers. We power nearly a billion conversational interactions every month, providing uniquely rich data analytics and safety tools to unlock the power of conversational AI for better business outcomes. Fast Company named LivePerson the #1 Most Innovative AI Company in the world. Learn more at liveperson.com.
Investor
Feb 2022
Teladoc Health is the global leader in virtual care, delivering and orchestrating care across patients, care providers, platforms and partners – transforming virtual care into a catalyst for how better health happens. Our comprehensive care offerings span primary care, mental health, chronic condition management and more, all integrated on a single platform.
We partner with employers, health plans, hospitals, health systems and other providers to fuel clinical excellence and apply the power of technology to help people live their healthiest lives.
Follow us for industry insights, virtual care trends, client success stories and expert perspectives shaping the future of healthcare.
For more information, please visit www.teladochealth.com or follow @TeladocHealth on X.
Investor
Jan 2022
A leading provider of virtual mental health care, Talkspace provides convenient access to high-quality, evidence-based therapy, psychiatry, and self-guided support. The Talkspace network of 5,000+ licensed clinicians includes therapists and psychiatric providers with specialized knowledge of more than 150 conditions and treatment approaches. Founded in 2012, Talkspace pioneered message-based therapy, fulfilling an unmet desire of many people to text with a therapist, any time, from anywhere. We have grown into a single destination for comprehensive mental health care, including specialized therapy for individuals, couples, and teens, psychiatry and medication management, and self-guided tools and resources. All care is delivered through our fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. More than 130 million people have access to Talkspace through their health plans for the cost of a copay or free through their employer, college or university, school district, or government agency. Making high-quality mental health support available to all is the Talkspace mission, and we’re just getting started.
Investor
Jan 2022
LifeStance Health is a behavioral health care company focused on providing evidenced-based, medically driven treatment services for children, adolescents and adults suffering from a variety of mental health issues in care settings that include acute inpatient, partial hospitalization, intensive outpatient, outpatient, community-based and in-home.
Our Vision: A truly healthy society where mental and physical healthcare are unified to make lives better.
Our Mission: To help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental healthcare.
Our Values:
* Delivering Compassion - We care for people unconditionally and act with empathy always.
* Building Relationships - We are collaborative, building enduring relationships to achieve more together.
* Celebrating Difference - We respect the diversity of every individual’s lived experiences.
Show all 49 entries ↓
Investment activity
1996–2023 · 43 investments
Recent (last 2 years)Earlier
